Dasatinib-Associated Acneiform Eruption Successfully Treated With Sarecycline in a Patient With Chronic Myeloid Leukemia

Dasatinib is a second-generation tyrosine inhibitor that is used for the treatment of patients with chronic myeloid leukemia (CML). It can cause a myriad of skin toxicities, including pruritis, pigmentary abnormalities of hair and skin, and maculopapular rashes. Rarely, it can be associated with acn...

Descripción completa

Detalles Bibliográficos
Autores principales: Poplausky, Dina, Young, Jade N, Dubin, Danielle P, Tremblay, Douglas, Gulati, Nicholas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2023
Materias:
Dermatology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10590148/
https://www.ncbi.nlm.nih.gov/pubmed/37868438
http://dx.doi.org/10.7759/cureus.45697

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10590148/
https://www.ncbi.nlm.nih.gov/pubmed/37868438
http://dx.doi.org/10.7759/cureus.45697

Ejemplares similares